Literature DB >> 15790777

Cycling G1 CD34+/CD38+ cells potentiate the motility and engraftment of quiescent G0 CD34+/CD38-/low severe combined immunodeficiency repopulating cells.

Tamara Byk1, Joy Kahn, Orit Kollet, Isabelle Petit, Sarit Samira, Shoham Shivtiel, Herzl Ben-Hur, Amnon Peled, Wanda Piacibello, Tsvee Lapidot.   

Abstract

The mechanism of human stem cell expansion ex vivo is not fully understood. Furthermore, little is known about the mechanisms of human stem cell homing/repopulation and the role that differentiating progenitor cells may play in these processes. We report that 2- to 3-day in vitro cytokine stimulation of human cord blood CD34(+)-enriched cells induces the production of short-term repopulating, cycling G1 CD34(+)/CD38(+) cells with increased matrix metalloproteinase (MMP)-9 secretion as well as increased migration capacity to the chemokine stromal cell-derived factor-1 (SDF-1) and homing to the bone marrow of irradiated nonobese diabetic severe/combined immunodeficiency (NOD/SCID) mice. These cycling G1 cells enhance SDF-1-mediated in vitro migration and in vivo homing of quiescent G0 CD34(+) cells, which is partially abrogated after inhibition of MMP-2/-9 activity. Moreover, the engraftment potential of quiescent G0 SCID repopulating cells (SRCs) is also increased by the cycling G1 CD34(+)/CD38(+) cells. This effect is significantly abrogated after incubation of cycling G1 cells with a neutralizing anti-CXCR4 antibody. Our data suggest synergistic interactions between accessory cycling G1 CD34(+)/CD38(+) committed progenitor cells and quiescent, primitive G0 CD34(+)/CD38(-/low) SRC/stem cells, the former increasing the motility and engraftment potential of the latter, partly via secretion of MMP-9.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790777     DOI: 10.1634/stemcells.2004-0060

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  4 in total

1.  Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.

Authors:  Katelyn E Masiuk; Devin Brown; Jennifer Laborada; Roger P Hollis; Fabrizia Urbinati; Donald B Kohn
Journal:  Mol Ther       Date:  2017-06-27       Impact factor: 11.454

2.  Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approach.

Authors:  Julie Lang; Nicholas Weiss; Brian M Freed; Raul M Torres; Roberta Pelanda
Journal:  Clin Immunol       Date:  2011-04-14       Impact factor: 3.969

Review 3.  Challenges for heart disease stem cell therapy.

Authors:  Jane Hoover-Plow; Yanqing Gong
Journal:  Vasc Health Risk Manag       Date:  2012-02-17

4.  CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules.

Authors:  Shoham Shivtiel; Orit Kollet; Kfir Lapid; Amir Schajnovitz; Polina Goichberg; Alexander Kalinkovich; Elias Shezen; Melania Tesio; Neta Netzer; Isabelle Petit; Amnon Sharir; Tsvee Lapidot
Journal:  J Exp Med       Date:  2008-09-08       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.